$CBT News

Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029

Cabot (CBT) Q3 2026 Earnings Call Transcript

JP Morgan Maintains Underweight on Cabot, Raises Price Target to $78

UBS Maintains Neutral on Cabot, Lowers Price Target to $92

Cabot Corporation 2026 Q3 - Results - Earnings Call Presentation

Cabot Q3 Earnings Call Highlights

Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth and ...

Cabot Corporation (CBT) Q3 2026 Earnings Call Transcript

Cabot Corporation Q3 2026 Earnings Call Summary

Cabot Q3 2026 Earnings Call Transcript

Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)

Cabot (CBT) Tops Q3 Earnings and Revenue Estimates

Cabot Q3 Adj. EPS $1.67 Beats $1.66 Estimate, Sales $982.000M Beat $931.402M Estimate

Cabot Narrows FY2026 Adj EPS Guidance from $6.00-$6.50 to $6.15-$6.45 vs $6.33 Est

How Cabot’s 2026 CEO Transition to Erica McLaughlin May Shape Cabot (CBT) Investors

Cabot Corporation Announces Planned Leadership Transition

Cabot President, CEO Sean Keohane Intends To Retire, Effective Sept. 30; CFO Erica McLaughlin Appointed Successor

All You Need to Know About Cabot (CBT) Rating Upgrade to Buy

Cabot Corporation Board Declares Dividend

Cabot Corporation to Announce Third Quarter Fiscal 2026 Operating Results